Intuitive Surgical, Inc. (ISRG) fair value analysis

S&P 500 · Updated 2026-09-07

Intuitive Surgical, Inc. designs, manufactures, and markets robotic systems used in minimally invasive surgery, along with related instruments and accessories. The company operates globally, serving hospitals and surgical centers across multiple continents.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, ISRG is trading at more than a 25% discount to estimated fair value.

ISRG currently ranks #19 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $366.70
Sector: Healthcare
12-month range: $353.33–$567.37

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: A
Margin trend: Stable
Revenue growth: Strong
RSI zone: Neutral
52-week position: The bottom quarter of its range

What our data shows for ISRG

Our model validated 17 trailing price-to-earnings windows for ISRG, built from quarterly earnings records.
Shares are trading in the lower third of their 12-month price range of $353.33–$567.37.
The 14-day relative strength index sits at a neutral 45.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for ISRG
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent ISRG news

TickrTrends' derived news-sentiment signal for ISRG is currently leaning positive, computed from recent coverage.

Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth (finance.yahoo.com, 2026-09-07)
TickrTrends take: Intuitive Surgical operates in the Healthcare sector where technological advancement directly impacts competitive positioning and long-term revenue potential. The company's integration of AI innovations into its robotic surgery platform represents a material capability enhancement that could influence its market opportunity and operational efficiency metrics going forward. Given TickrTrends' current undervalued assessment, investors monitoring valuation trends should track whether this AI development translates into measurable improvements in adoption rates, procedure volumes, or margin expansion.
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? (finance.yahoo.com, 2026-09-05)
TickrTrends take: Intuitive Surgical's moderating growth trajectory from pandemic-era peaks presents a valuation consideration for investors monitoring the Healthcare sector. TickrTrends currently derives an Undervalued verdict for ISRG, suggesting the market may not be fully pricing in the company's longer-term potential despite near-term growth normalization. Investors should track whether the company's core robotics business can sustain adequate adoption rates and procedure volumes that justify current valuation multiples, particularly as growth rates settle into more normalized patterns.
How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks? (finance.yahoo.com, 2026-09-01)
TickrTrends take: Intuitive Surgical operates in a healthcare equipment subsector where valuation multiples can vary significantly based on competitive positioning and growth trajectories. Given TickrTrends' undervalued assessment, investors focused on valuation metrics should monitor whether ISRG's stock performance relative to peers reflects a genuine discount or represents a temporary market repricing. The relative performance comparison becomes particularly relevant for those seeking to understand if ISRG's current valuation gap versus comparable healthcare equipment manufacturers persists or narrows.

What people are saying

Follow the ISRG conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is ISRG stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), ISRG is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is ISRG's TickrTrends verdict?

ISRG's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does ISRG compare to other Healthcare stocks?

ISRG ranks #19 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is ISRG overbought or oversold?

ISRG's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

ISRG vs AMPH · ISRG vs COO · ISRG vs DXCM · ISRG vs HALO · ISRG vs HQY